Offer - Urjas Oil for just ₹ 1 X
Pre OP 500 Mg/250 Mg Injection is a prescription drug, available for use as Injection. Pre OP 500 Mg/250 Mg Injection also has some secondary and off-label uses. These are listed below.
The correct dosage of Pre OP 500 Mg/250 Mg Injection depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Pre OP 500 Mg/250 Mg Injection can also lead to other problems, which have been listed below. These side effects of Pre OP 500 Mg/250 Mg Injection are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Pre OP 500 Mg/250 Mg Injection's effect during pregnancy is Safe and Safe while nursing. In addition, Pre OP 500 Mg/250 Mg Injection's effects on the liver, heart and kidney are discussed below in the Pre OP 500 Mg/250 Mg Injection related warnings section.
Pre OP 500 Mg/250 Mg Injection can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Pre OP 500 Mg/250 Mg Injection in conditions like Kidney Disease, Kidney Disease, Jaundice. The section on Pre OP 500 Mg/250 Mg Injection contraindications lists all such conditions.
Besides this, Pre OP 500 Mg/250 Mg Injection may also have severe interaction with some medicines. Refer to the list below for further details.
In addition to the above precautions for Pre OP 500 Mg/250 Mg Injection, it is important to know that it is not safe while driving, and is not habit-forming.
Pre OP 500 Mg/250 Mg Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Pre OP 500 Mg/250 Mg Injection safe for pregnant women?
Pregnant women can take Pre Op safely.
Is the use of Pre OP 500 Mg/250 Mg Injection safe during breastfeeding?
Pre Op does not show any harmful effects in lactating women.
What is the effect of Pre OP 500 Mg/250 Mg Injection on the Kidneys?
Pre Op rarely affects the kidneys.
What is the effect of Pre OP 500 Mg/250 Mg Injection on the Liver?
Pre Op is completely safe for the liver.
What is the effect of Pre OP 500 Mg/250 Mg Injection on the Heart?
There are no any side effects of Pre Op for the heart.
If you are suffering from any of the following diseases, you should not take Pre OP 500 Mg/250 Mg Injection unless your doctor advises you to do so -
Is this Pre OP 500 Mg/250 Mg Injection habit forming or addictive?
No, you will not get addicted to Pre OP 500 Mg/250 Mg Injection.
Interaction between Food and Pre OP 500 Mg/250 Mg Injection
When consumed with certain foods, Pre OP 500 Mg/250 Mg Injection may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Pre OP 500 Mg/250 Mg Injection
Information about the interaction of Pre OP 500 Mg/250 Mg Injection and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ampicillin
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 722-723
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 158-160
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; UNASYN® (ampicillin sodium/sulbactam sodium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 725
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 160-162